glycerophosphoinositol 4,5-bisphosphate has been researched along with Carcinoma, Anaplastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Backer, JM; Cammer, M; Chen, X; Condeelis, JS; Desmarais, V; Eddy, RJ; Song, X; van Rheenen, J; van Roosmalen, W; Yip, SC | 1 |
Bezprozvanny, I; Gusev, K; Kaznacheyeva, E; Mozhayeva, GN; Zubov, A | 1 |
2 other study(ies) available for glycerophosphoinositol 4,5-bisphosphate and Carcinoma, Anaplastic
Article | Year |
---|---|
EGF-induced PIP2 hydrolysis releases and activates cofilin locally in carcinoma cells.
Topics: Actin Depolymerizing Factors; Actins; Animals; Breast Neoplasms; Carcinoma; Cell Line; Cell Membrane; Epidermal Growth Factor; Female; Hydrolysis; Phosphatidylinositol 4,5-Diphosphate; Protein Transport; Rats | 2007 |
Activation of calcium entry in human carcinoma A431 cells by store depletion and phospholipase C- dependent mechanisms converge on ICRAC-like calcium channels.
Topics: Calcium; Calcium Channels; Carcinoma; Cell Membrane; Egtazic Acid; Electric Conductivity; Humans; Inositol 1,4,5-Trisphosphate; Ion Channel Gating; Models, Biological; Patch-Clamp Techniques; Phosphatidylinositol 4,5-Diphosphate; Thapsigargin; Tumor Cells, Cultured; Type C Phospholipases; Uridine Triphosphate | 2001 |